<?xml version="1.0" encoding="UTF-8"?>

<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>
<channel>
    	<title>IJPRS/V1/I2/00062 - 15/05/2012</title>

	<item>
		<title>Box-Behnken Design for Optimization of Formulation Variables of Tramadol HCl Sustained Release Matrix Tablet</title>
		
		<description><![CDATA[<h5>Author's Affiliation</h5>
		                                                <p></p>
		                                                <hr/>
                                                    	<h5>Abstract</h5>
		                                                <p>The objective of this work was to develop sustained release tablets (Once in a day) of highly water soluble Tramadol HCl using hydrophilic polymers (HPMC K100M, HPMC K15M, HPMC K 4M) as cost effective, non toxic easily available and suitable hydrophilic matrix system. Sustained release tablet of Tramadol HCl (dose 200mg) were produced by wet granulation method by PVP K30 5% solution. After the evaluation of physical characteristics of granules &amp; tablets, The dissolution test was performed in 0.1 N HCl for 2 hr and remaining 22 hr performed in 6.8 pH buffer solution. We concluded that T1-T15 batches of Box-behnken design passed the pre-compressional and post-compressional parameters and increasing the polymer concentration, decreasing the drug release. Higher viscosity grade HPMC K100M is more drug retarding agent as compare to HPMC K15M &amp; HPMC K4M.  In combination of HPMC K4M, HPMC K15M &amp; HPMC K100M, T7 batch having drug releasing up to 24 hrs as compare to others. Kinetics treatment of the box-behken design batches, concluded that zero order R<sup>2</sup> value is near to 0.999 as compared to the first order R<sup>2</sup> value. So, all batches follow the Zero order release mechanism. From the korsmeyer-peppas model, concluded that drug release mechanism is diffusion with dissolution or anomalous diffusion (Non-fickian). From the statastical analysis full model and reduced model was analyzed and got the significant effect of X<sub>3</sub> polymer as compared to X<sub>1</sub> &amp; X<sub>2</sub>. X<sub>3</sub> having more negative value than the X<sub>1</sub> &amp; X<sub>2</sub> so concluded that the X<sub>3</sub> polymer is effective to retardation of the drug release. T1-T15 batches are compared with marketed product (Tramazac OD tab.). T7 batch had more 73.58 similarity factor (<em>f</em><sub>2</sub>) when Marketed formulation taken as a reference. So T7 batch is optimized batch. The optimized batch is passed the accelerated stability studies, No significant change in the dissolution profile.</p>
                                                    	<hr/>
                                                        <h5>Keywords</h5>
                                                         <p>Box-Behnken Design, Hydroxypropylmethylcellulose, PVP K-30, Sustained Release, Tramadol HCl, Wet Granulation</p>
                                                         
                                                    	                                                    	<hr/>
                                                         <h5>Cite This Article</h5>
                                                         <p>Gandhi, C.K., Mehta, T.J., Patel, M.R., Patel, K.R., Patel, N.M. (2012). Box-Behnken Design for Optimization of Formulation Variables of Tramadol HCl Sustained Release Matrix Tablet, <em>International Journal for Pharmaceutical Research Scholars</em> <em>(IJPRS)</em>, 1(2), 99-114.</p>                                                         <hr/>
                                                         <p><a class="a2a_button_facebook" href="https://www.addtoany.com/add_to/facebook?linkurl=https%3A%2F%2Fwww.ijprs.com%2Farticle%2Fbox-behnken-design-for-optimization-of-formulation-variables-of-tramadol-hcl-sustained-release-matrix-tablet%2F&amp;linkname=Box-Behnken%20Design%20for%20Optimization%20of%20Formulation%20Variables%20of%20Tramadol%20HCl%20Sustained%20Release%20Matrix%20Tablet" title="Facebook" rel="nofollow noopener" target="_blank"></a><a class="a2a_button_twitter" href="https://www.addtoany.com/add_to/twitter?linkurl=https%3A%2F%2Fwww.ijprs.com%2Farticle%2Fbox-behnken-design-for-optimization-of-formulation-variables-of-tramadol-hcl-sustained-release-matrix-tablet%2F&amp;linkname=Box-Behnken%20Design%20for%20Optimization%20of%20Formulation%20Variables%20of%20Tramadol%20HCl%20Sustained%20Release%20Matrix%20Tablet" title="Twitter" rel="nofollow noopener" target="_blank"></a><a class="a2a_dd addtoany_share_save addtoany_share" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.ijprs.com%2Farticle%2Fbox-behnken-design-for-optimization-of-formulation-variables-of-tramadol-hcl-sustained-release-matrix-tablet%2F&#038;title=Box-Behnken%20Design%20for%20Optimization%20of%20Formulation%20Variables%20of%20Tramadol%20HCl%20Sustained%20Release%20Matrix%20Tablet" data-a2a-url="https://www.ijprs.com/article/box-behnken-design-for-optimization-of-formulation-variables-of-tramadol-hcl-sustained-release-matrix-tablet/" data-a2a-title="Box-Behnken Design for Optimization of Formulation Variables of Tramadol HCl Sustained Release Matrix Tablet"></a></p>]]>
        </description>
		<link>https://www.ijprs.com/article/box-behnken-design-for-optimization-of-formulation-variables-of-tramadol-hcl-sustained-release-matrix-tablet/</link>
		<author>Gandhi, C.K., Mehta, T.J., Patel, M.R., Patel, K.R., Patel, N.M.        </author>

		<pdflink>http://www.ijprs.com/wp-content/uploads/2018/09/IJPRS-V1-I2-00062.pdf</pdflink>

	</item>
</channel>
</rss>
